Page last updated: 2024-11-07

alpha-methyl-beta-hydroxybutyrate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-methyl-3-hydroxybutyric acid: metabolite from isoleucine; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-hydroxy-2-methylbutanoic acid : A 3-hydroxy monocarboxylic acid that is butyric acid which is substituted by a methyl group and a hydroxy group at positions 2 and 3, respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID160471
CHEBI ID37051
SCHEMBL ID55047
MeSH IDM0066680

Synonyms (30)

Synonym
2-methyl-3-hydroxybutanoic acid
3-hydroxy-2-methylbutyric acid
3-hydroxy-2-methylbutanoic acid
2-methyl-3-hydroxybutyric acid
CHEBI:37051
nilic acid
FT-0669769
LMFA01050391
2-methyl-3-hydroxy-2-butanoic acid
473-86-9
butanoic acid, 3-hydroxy-2-methyl-
alpha-methyl-beta-hydroxybutyrate
AKOS011684293
SCHEMBL55047
3-hydroxy-2-methylbutyrate
2-methyl-3-hydroxybutanoate
3-hydroxy-2-methyl-butanoic acid
methyl-3-hydroxybutyric acid
3-hydroxy-2-methyl-butyric acid
a-methyl-b-hydroxybutyric acid
3-hydroxy-2-methyl-butyrate
a-methyl-b-hydroxybutyrate
alpha-methyl-beta-hydroxybutyric acid
DTXSID90861980
3-hydroxy-2-methyl butanoic acid
Q27117024
EN300-149138
3-hydroxy-2-methylbutanoicacid
CS-0116129
Z982137146
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
3-hydroxy monocarboxylic acidA hydroxy monocarboxylic acid that has a hydroxy group beta to the carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (43.48)18.7374
1990's1 (4.35)18.2507
2000's6 (26.09)29.6817
2010's6 (26.09)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.91 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index5.09 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies11 (47.83%)4.05%
Observational0 (0.00%)0.25%
Other12 (52.17%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]